2013 Clinical Trials Consumption Patients 
FloridaMarijuana.net
AUGUST 9, 2018
Because there is limited or conflicting research about “the true nature of traumatic brain injury and how it causes chronic degenerative problems,” treatment can be a challenging process for many patients. One medication may work for one patient, but might be ineffective for another TBI patient.
The Cannigma
MAY 13, 2022
There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. One of the major reasons cannabis grew so popular with medical marijuana patients is its perceived ability to manage pain, particularly pain that other medications can’t help. And this is an area of ample scientific research.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MARCH 7, 2019
Switzerland’s government will allow 5,000 citizens to use cannabis legally, as part of a country-wide clinical trial. Those who sign up to the trial would receive a small amount of cannabis each month, to smoke or eat. Currently, consumption of cannabis containing up to one percent tetrahydrocannabinol (THC) is legal.
Alchimia
OCTOBER 15, 2021
For example, in a 2013 study, the smokers who used a CBD inhaler reduced the number of cigarettes they smoked each day by 40%. This can be very painful, but cannabidiol’s anti-inflammatory properties could help alleviate the discomfort, and improve the patient mobility during their recovery. 9- Stuttering.
Cannabis Law Report
JUNE 30, 2019
The Delaware Senate passes legislation making violation of cannabis consumption/possession laws by minors a civil rather than criminal infraction. Louisiana John Bel Edwards (D) signed a bill modifying his state’s medical cannabis law to allow patients to inhale medical cannabis and setting fees on sales.
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.
Expert insights. Personalized for you.
190 
Let's personalize your content